Budd-Chiari syndrome

What it is

From: Orphanet

A rare vascular liver disease characterized by obstruction of hepatic venous outflow involving either the hepatic veins or the terminal segment of the inferior vena cava.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Ascites · Very frequent (99-80%)

Accumulation of fluid in the peritoneal cavity (between the layers of the peritoneum that lines the abdomen).

Portal hypertension · Very frequent (99-80%)

Increased pressure in the portal vein.

Splenomegaly · Very frequent (99-80%)

Abnormal increased size of the spleen.

Abdominal pain · Frequent (79-30%)

An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) and perceived to originate in the abdomen.

Bipedal edema · Frequent (79-30%)

A palpable swelling in both feet and ankles caused by an increase in interstitial fluid volume (excess fluid).

Cirrhosis · Frequent (79-30%)

A chronic disorder of the liver in which liver tissue becomes scarred and is partially replaced by regenerative nodules and fibrotic tissue resulting in loss of liver function.

Elevated circulating alkaline phosphatase concentration · Frequent (79-30%)

Abnormally increased serum levels of alkaline phosphatase activity.

Elevated circulating hepatic transaminase concentration · Frequent (79-30%)

Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result of liver or heart damage. SGOT and SGPT are used clinically mainly as markers of liver damage.

Esophageal varix · Frequent (79-30%)

Extreme dilation of the submucusoal veins in the lower portion of the esophagus.

Fever · Frequent (79-30%)

Body temperature elevated above the normal range.

Hepatic vein thrombosis · Frequent (79-30%)

An obstruction in the veins of the liver caused by a blood clot (thrombosis).

Hepatomegaly · Frequent (79-30%)

Abnormally increased size of the liver.

Acute hepatic failure · Occasional (29-5%)

Hepatic failure refers to the inability of the liver to perform its normal synthetic and metabolic functions, which can result in coagulopathy and alteration in the mental status of a previously healthy individual. Hepatic failure is defined as acute if there is onset of encephalopathy within 8 weeks of the onset of symptoms in a patient with a previously healthy liver.

Cholecystitis · Occasional (29-5%)

The presence of inflammatory changes in the gallbladder.

Other findings in the same source

From: Orphanet

Additional reported features include Gastrointestinal hemorrhage (Occasional (29-5%)); Hepatic encephalopathy (Occasional (29-5%)); Intestinal obstruction (Occasional (29-5%)); Jaundice (Occasional (29-5%)); Malabsorption (Occasional (29-5%)); Peritonitis (Occasional (29-5%)); Renal insufficiency (Occasional (29-5%)); Weight loss (Occasional (29-5%)); Gastrointestinal infarctions (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.

When it may begin

From: Orphanet

All ages

Inheritance in the source

From: Orphanet

Multigenic/multifactorial

Frequency and the population described

From: Orphanet

Point prevalence: 1-9 / 100 000; Europe; Value and class. Annual incidence: <1 / 1 000 000; Sweden; Value and class. Point prevalence: 1-9 / 1 000 000; Sweden; Value and class. Annual incidence: <1 / 1 000 000; Denmark; Value and class.

Which doctor should you see?

The suggested department for discussing Budd-Chiari syndrome is Hepatology, with a hepatologist / gastroenterologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.

Additional services that may be relevant, depending on the findings, include: Clinical Genetics.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

• What is known about the cause and extent of liver involvement?
• Which medicines, supplements or exposures should be reviewed?
• What follow-up is appropriate for the specific diagnosis and stage?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Budd-Chiari syndrome. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.